Video

How Otsuka Is Incorporating Patient-Facing Technologies Into Protocols

Source: Clinical Leader
20_05_CLL_EmbracingVirtualTrials_1920x1080_Segments_PatientFacingTechnologies

In May 2020 Clinical Leader Live was proud to feature Brian Johnson, Director of Applied Innovation at Otsuka, and Katherine Vandebelt, Global Head of Clinical Innovation for Oracle to discuss whether pharma companies were ready to embrace virtual trials. During the presentation, Johnson and Vandebelt covered several topics, including how COVID-19 has changed the view of virtual trials, whether they will become a future best practice, how Otsuka opted to be a leader in the adoption of virtual technologies, the challenges and benefits of implementing virtual trials, incorporating virtual components into trial protocols, the impact these technologies can have on recruitment and retention, and therapeutic areas where virtual trials might have the biggest impact.

In this video, Johnson discusses what Otsuka is doing to properly incorporate virtual components into its trial protocols.

Or click here to see the complete interview.

VIEW THE VIDEO!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader